Chronic Lymphocytic Leukemia Advisor – Cancer Therapy Advisor
Cancer Therapy Advisor |
Chronic Lymphocytic Leukemia Advisor
Cancer Therapy Advisor Evidence published in the Journal of Clinical Oncology demonstrates that anti-CD19 chimeric antigen receptor-modified T (CAR–T) cell therapy is highly effective in treating high-risk patients with chronic lymphocytic leukemia (CLL) previously treated … CAR T-Cell Therapy for Leukemia Leads to Remissions in Clinical Trial |
